Found: 2
Select item for more details and to access through your institution.
Attenuated cytarabine, etoposide, dexamethasone plus rituximab (R‐Mini‐CYVE) regimen for patients with relapsed or refractory B‐cell non–Hodgkin's lymphoma not eligible for intensive chemotherapy.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 4, p. 574, doi. 10.1111/ejh.13589
- By:
- Publication type:
- Article
LONG‐TERM OUTCOMES OF ELDERLY PATIENTS TREATED WITH FRONTLINE R‐CHOP: UPDATE OF THE LNH03‐6B TRIAL.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.96_2880
- By:
- Publication type:
- Article